Edition:
United Kingdom

Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

26.14USD
20 Jul 2018
Change (% chg)

$0.14 (+0.54%)
Prev Close
$26.00
Open
$26.06
Day's High
$26.26
Day's Low
$25.92
Volume
355,588
Avg. Vol
777,874
52-wk High
$27.32
52-wk Low
$7.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.48 -0.214
Dec 0.60 -0.016
Sep 0.69 -0.811
FY 2017 Jun '17 0.64 -0.485
Mar '17 1.32 -0.550
Dec 0.38 -0.234
Sep 0.74 -0.169
FY 2016 Jun '16 0.93 -0.167
Mar '16 0.90 -0.148
Dec 0.67 -0.145
Sep 0.73 -0.163
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 4.27 12.70 0.00 --
Quarter Ending Jun-18 3 4.27 12.70 0.00 12.70
Year Ending Jun-18 4 5.15 14.40 1.80 18.87
Year Ending Jun-19 4 31.00 58.30 7.00 44.95
Earnings (per share)
Quarter Ending Mar-18 3 -0.15 -0.04 -0.21 --
Quarter Ending Jun-18 4 -0.22 -0.05 -0.31 -0.06
Year Ending Jun-18 3 -1.26 -1.24 -1.29 -0.56
Year Ending Jun-19 4 -0.92 -0.57 -1.41 -0.77
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.33 32.76
P/E High - Last 5 Yrs. -- 298.33 45.44
P/E Low - Last 5 Yrs. -- 91.43 24.26
Beta 1.59 0.93 0.89
Price to Sales (TTM) 472.92 112.52 5.73
Price to Book (MRQ) -- 15.54 5.47
Price to Tangible Book (MRQ) -- 14.64 7.05
Price to Cash Flow (TTM) -- 72.59 23.29
% Owned Institutions 74.12 14.53 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg 0.00 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.35 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -31.15 408.02 8.01
Sales (TTM) vs TTM 1 Yr. Ago -4.39 79.88 5.64
Sales - 5 Yr. Growth Rate -37.62 32.06 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -189.81 29.02 20.60
EPS (TTM) vs TTM 1 Yr. Ago -130.72 -- --
EPS - 5 Yr. Growth Rate -- 39.49 10.66
Capital Spending - 5 Yr. Growth Rate 26.46 39.97 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.28 1.92 2.22
Current Ratio (MRQ) 1.29 5.50 3.03
LT Debt to Equity (MRQ) -- 34.92 12.51
Total Debt to Equity (MRQ) -- 36.72 16.84
Interest Coverage (TTM) -11.39 -101.16 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 84.39 39.68 54.37
Gross Margin - 5 Yr. Avg. 85.27 50.98 52.17
EBITD Margin (TTM) -2,530.57 -- --
EBITD - 5 Yr. Avg -950.32 -586.56 10.81
Operating Margin (TTM) -2,560.44 -733.21 4.58
Operating Margin - 5 Yr. Avg. -900.69 -608.15 6.23
Pre-Tax Margin (TTM) -4,957.38 -707.36 5.43
Pre-Tax Margin - 5 Yr. Avg. -1,202.66 -611.67 6.67
Net Profit Margin (TTM) -4,958.05 -708.75 1.73
Net Profit Margin - 5 Yr. Avg. -1,183.71 -614.69 2.94
Effective Tax Rate (TTM) -- 23.23 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.56 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 22,400 23,025,841 860,394,083
Net Income/Employee (TTM) -1,110,625 3,117,868 101,209,433
Receivable Turnover (TTM) 6.17 20.74 5.87
Inventory Turnover (TTM) 1.04 2.46 3.41
Asset Turnover (TTM) 0.03 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -139.64 0.27 11.14
Return on Assets - 5 Yr. Avg. -85.73 3.72 12.40
Return on Investment (TTM) -367.82 2.22 14.61
Return on Investment - 5 Yr. Avg. -119.48 2.89 16.14
Return on Equity (TTM) -- 3.86 16.34
Return on Equity - 5 Yr. Avg. -4,597.47 3.83 17.40
  1 Year 3 Year 5 Year
Sales % -4.39 -30.08 -37.62
EPS (TTM) % -135.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immunomedics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.19 -4.59 72 53
13 Week 38.48 31.74 99 66
26 Week 99.15 84.01 99 79
52 Week 346.74 278.65 99 52
YTD 217.71 179.01 99 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 72.52%
# of Holders: 234
Total Shares Held: 129,605,592
3 Mo. Net Change: 2,610,212
# New Positions: 5
# Closed Positions: 2
# Increased Positions: 21
# Reduced Positions: 10
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.